Presentation TCT 2014 24h Ambulatory Blood Pressure (ABPM) Change After Using The New Symplicity Spyral Renal Sympathetic Denervation Device In Patients With Resistant Hypertension ? First Results Fr___ Presenter: Alexander Plehn September 16, 2014
Presentation TCT 2014 TCT 407: Evaluation of the Acute and Long-term Renal Artery Reinnervation Attempt Response Following Catheter-Based Renal Denervation in a Swine Model: An Immunohistochemical Characterization Presenter: David P. Faxon, Armando Tellez, MD September 15, 2014
Presentation TCT 2014 Renal Denervation for Chronic Kidney Disease: Status and Case Example Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Felix Mahfoud September 14, 2014
Presentation TCT 2014 Renal Denervation for Congestive Heart Failure: Status and Case Example Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Justin E. Davies September 14, 2014
Presentation TCT 2014 Renal Denervation for Atrial and Ventricular Arrhythmias: Status and Case Examples Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Vivek Y. Reddy September 14, 2014
Presentation TCT 2014 Extravascular Focused Ultrasound for Renal Denervation: Kona Medical Update Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, John A. Ormiston September 14, 2014
Presentation TCT 2014 Early Stage or Uncontrolled Hypertension! Presenter: Darrel P. Francis September 14, 2014
Presentation TCT 2014 TCT 406: Renal Artery Trauma Induced by Four Different Renal Denervation Systems: A Multimodality Intraarterial Imaging Study Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Antonios Karanasos September 14, 2014
Presentation TCT 2014 Updates and Status of the Cordis Renlane Program Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Felix Mahfoud September 14, 2014
Presentation TCT 2014 Updates and Status of the ReCor Paradise Program Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Thomas Zeller September 14, 2014
Presentation TCT 2014 Going to the Source: Early Clinical Results with the Afferently Directed Nonvascular Renal Denervation System (Verve Medical) Presenter: Frank Litvack, Richard R. Heuser September 14, 2014
Presentation TCT 2014 Updates and Status of the St. Jude EnligHTN Program Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray September 14, 2014
Presentation TCT 2014 Updates and Status of the Boston Scientific Vessix Program Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Ajay J. Kirtane September 14, 2014
Presentation TCT 2014 From SYMPLICITY HTN-1 to the Global SYMPLICITY Registry and Beyond: Updates from and Status of the SYMPLICITY Clinical Trial Program Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Michael Boehm September 14, 2014
Presentation TCT 2014 TCT 405: SYMPLICITY HTN-3: Outcomes in the African-American and NonAfrican American Populations Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, John Flack September 14, 2014
Presentation TCT 2014 First Deep Dive into SYMPLICITY HTN-3: Primary Results and Updated Analyses Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray September 14, 2014
Presentation TCT 2014 Renal Denervation: Boom or Bust? Presenter: Martina Kelly Speight, Sarah Clarke, Ajay J. Kirtane September 14, 2014
Presentation TCT 2014 Is Renal Denervation a Blockbuster Therapy or Have We Ground to a Halt? Presenter: Jose Luis Assad-Morell, Efrain Gaxiola, Armando Tellez September 13, 2014
Presentation TCT 2014 Guidelines and Recommendations for the Practical Application of Renal Denervation Therapies in a Post-SYMPLICITY 3 World Presenter: Ajay J. Kirtane, Felix Mahfoud, John A. Ormiston, Thomas F. Luscher September 13, 2014